Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- Check7 days agoChange DetectedRevision history now includes v3.4.3 and removes v3.4.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry, v3.4.2, was added to the study record history; a government-funding operating-status notice and the prior revision note v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedA site-wide notice about a lapse in government funding and current operating status was added, directing users to official status sources. The revision tag was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.7%

- Check49 days agoChange DetectedThe history page now includes a glossary toggle and color-coded highlights (green for additions, red for deletions) with a new Revision: v3.4.0 tag. The previous Revision: v3.3.4 entry and the No FEAR Act data entry were removed.SummaryDifference1.0%

- Check63 days agoChange DetectedVersion v3.3.4 appears in the page history, replacing v3.3.3. This is a minor site revision and does not modify study data or user-facing content.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.